Tacalcitol

DB13689InvestigationalSmall molecule

Tacalcitol is a vitamin D analog indicated in the treatment of mild to moderate plaque psoriasis. A medication used to treat certain skin conditions.

Chemical structure of Tacalcitol
Mechanism
Curator reviewed
Formula / weight
C27H44O3 · 416.646 g/mol (avg)

Resolves to

Compound
UNIIC2W72OJ5ZUCAS57333-96-7ChEMBLCHEMBL2105611
Clinical / RWD
RxNorm291204ATCD05AX04
Structure
InChIKeyBJYLYJCXYAMOFT-RSFVBTMBSA-NSMILESCC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C
Targets
P11473VDR

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
17Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
10ContraindicationsEach with its own population and attribute set
Sign in
10Marketed productsAcross 2 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tacalcitol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In